Statements (10)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:SPT_614
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Sumitomo_Pharma
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sumitomo Pharma SPT 614
|
| gptkbp:mechanismOfAction |
unknown
|
| gptkbp:status |
investigational drug
|
| gptkbp:therapeuticArea |
psychiatric disorders
|
| gptkbp:bfsParent |
gptkb:SPT_614
|
| gptkbp:bfsLayer |
8
|